Investment
Features
FeesSafety
Academy
More
Pluang+

Century Therapeutics rated speculative Buy on promising diabetes drug and solid cash runway.

Analyst Insights
30 Sep 2026
Seeking Alpha
View Source
Bullish
Century Therapeutics rated speculative Buy on promising diabetes drug and solid cash runway.

Century Therapeutics is rated a speculative Buy with an equity value of about $363 million, focusing on its CNTY-813 therapy for type 1 diabetes. The therapy aims to provide insulin-producing islets without the need for chronic immunosuppression, using advanced genetic edits. Strong preclinical results and a cash runway into early 2029 support the investment case, though the lack of human trial data and potential stock dilution pose risks. Key upcoming milestones include an IND submission in late 2026 and initial human data expected in mid-2027, with competition and execution challenges remaining significant.

Century Therapeutics is the subject, with Pluang market data as context for readers. As of Sep 30, 2026 14:41 WIB, among 100 priced Health-sector US stocks on Pluang, 59 rose and 37 fell. Notable movers include Enveric Biosciences Inc (ENVB) at USD 1.43 with a 1-day change of -2.72%, 10X Genomics Inc (TXG) at USD 92.42 up 2.64%, and Twist Bioscience Corp (TWST) at USD 190.86 up 2.54%. The typical hold time on Pluang ranges from 13 to 93 days, with Pluang order activity varying from 5% to 70% buy interest.

More News

1.6M ETH queued for staking activation in 28 days, locking $4.27B and impacting Ethereum supply and price.

1.6M ETH queued for staking activation in 28 days, locking $4.27B and impacting Ethereum supply and price.

As of September 30, 2026, 1,603,958 ETH worth about $4.27 billion are in the Ethereum staking entry queue, with a 28-day wait before activation. This locks a significant portion of ETH supply, reducing market liquidity and supporting the price despit...

Protocol Fundamentals
Neutral
4 hours ago
GameStop insiders buy $57M in shares after strong Q2, sparking stock rally and analyst buy rating.

GameStop insiders buy $57M in shares after strong Q2, sparking stock rally and analyst buy rating.

GameStop's CEO Ryan Cohen and other insiders bought a total of $57 million in shares in September, reversing previous selling trends. This insider buying followed a strong Q2 earnings report that showed record operating income and boosted collectible...

Market News
Bullish
4 hours ago
Worldcoin (WLD) jumps 4.33% in one hour, hitting $0.521 amid short liquidations.

Worldcoin (WLD) jumps 4.33% in one hour, hitting $0.521 amid short liquidations.

Worldcoin (WLD) experienced a sharp price increase of 4.33% within one hour, rising from $0.4994 to $0.521 as of 5:08 a.m. ET on September 30. This move also represents a 4.22% gain compared to the previous 24 hours. The price surge coincided with th...

Market News
Bullish
4 hours ago
Wallet accumulates 9.52M ETHFI tokens worth $7M, first buy in 2 years, signaling new market interest.

Wallet accumulates 9.52M ETHFI tokens worth $7M, first buy in 2 years, signaling new market interest.

A large wallet with address 0xd28…7c1e7 recently accumulated 9.52 million ETHFI tokens valued at about $6.99 million. This activity marks the wallet's first accumulation of ETHFI tokens in two years, with withdrawals occurring on September 29 and 30....

Technical Signals
Neutral
4 hours ago
492,721 QNT tokens worth $140M moved between unknown wallets amid rising institutional interest

492,721 QNT tokens worth $140M moved between unknown wallets amid rising institutional interest

Nearly half a million QNT tokens, valued at about $140 million, were transferred between anonymous wallets, marking one of the largest single moves of the token. This transfer represents roughly 4% of the total circulating QNT supply and comes as Qua...

Market News
Bullish
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App